Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2025-12-27 @ 9:29 PM
Study NCT ID:
NCT02397395
Status:
WITHDRAWN
Last Update Posted:
2015-07-17
First Post:
2015-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.
Sponsor:
Janssen R&D Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-05
Completion Date Type:
ESTIMATED
First Submit Date:
2015-03-19
First Submit QC Date:
None
Study First Post Date:
2015-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-15
Last Update Post Date:
2015-07-17
Last Update Post Date Type:
ESTIMATED